Objective: We studied whether the human placenta has the structural integrity to impede transplacental passage of cell-free human immunodeficiency virus (HIV)-1 or p24 antigen from the maternal to the fetal circulation.
Methods: Nine term human placentas from uncomplicated vaginal or cesarean section deliveries were studied ex vivo with a placental perfusion apparatus to determine whether cell-free HIV-1 at 200-2000 tissue culture infectious dose (TCID50/mL) would pass to the fetal circulation. Passage of virus or p24 was assessed by infectivity titration and/or p24 antigen capture enzyme immunoassay.
Results: Infectious HIV-1 was not detected in any of the fetal perfusate samples taken periodically during experiments. Low concentrations of HIV-1 p24 antigen, however, were detected in fetal perfusate samples from three placentas.
Conclusions: The term human placenta effectively impedes passage of cell-free HIV-1 from the maternal to the fetal circulation. However, it may be permeable to passage of p24 antigen.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/107155769400100109 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of fine antigenic epitopes of Tamdy virus glycoprotein Gn fragment and establishment of ELISA detection method.
Parasit Vectors
January 2025
College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China.
Background: Tamdy virus (TAMV) was first isolated in Uzbekistan and Turkmenistan. In 2018, it was found in China, marking its entry into the molecular research era. TAMV is linked to febrile diseases, but its epidemiology and spillover risks are poorly understood, necessitating urgent molecular research and detection method development.
View Article and Find Full Text PDFComparison: Imported and Indigenous HIV Fourth-generation immunodiagnostic kits.
Asian J Transfus Sci
December 2024
Immunodiagnostic Kit Laboratory, National Institute of Biologicals, Noida, Uttar Pradesh, India.
Early detection of any disease is always a life-saving methodology for human beings likewise the detection of p24 antigen is always better than the detection of HIV antibodies. In the current era, p24 antigen is added additionally in HIV antibodies detection assays and called HIV fourth-generation immunodiagnostic kit. The different HIV fourth-generation kit having different capacities to pick up the low concentration of analyte as well as represent the detection values in different units.
View Article and Find Full Text PDFThe feasibility and impact of deploying a four-tests panel at antenatal care in primary health care facilities of a developing country, Kenya.
Front Public Health
December 2024
Centre for Biotechnology Research Development (CBRD), Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Introduction: Contracting HIV, syphilis, hepatitis B virus (HBV), and malaria during pregnancy significantly affects the health of the woman, the pregnancy, and the unborn child. The World Health Organization (WHO) recommends testing pregnant women for these infections to achieve triple elimination of mother-to-child transmissions. However, this goal has not been fully realized in low- to medium-income countries, primarily due to segmented testing practices.
View Article and Find Full Text PDFTMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.
J Immunother Cancer
November 2024
Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands
Article Synopsis
- The study explores how the PD-1 immune checkpoint protein is regulated on CD8 T cells, aiming to find ways to lower its abundance without hindering T cell activation, which is crucial for effective cancer therapy.
- Researchers conducted a CRISPR-Cas9 screen on murine CD8 T cells to identify genes impacting PD-1 levels, discovering that inhibiting the TMED protein family, especially TMED10, could reduce PD-1 on the cell surface and enhance T cell function.
- The findings highlight a new regulatory mechanism for PD-1 and suggest that targeting TMED could be a promising therapeutic strategy to improve T cell responses in cancer treatment, as indicated by correlations in mouse models and patient survival data.
Mitochondrial resilience and antioxidant defence against HIV-1: unveiling the power of extracts and Shatavarin IV.
Front Microbiol
October 2024
Division of Virology, ICMR - National Institute of Translational Virology and AIDS Research, Pune, India.
Article Synopsis
- AR, an Ayurvedic botanical, was studied for its effects on HIV-1 replication and its ability to reduce mitochondrial dysfunction during infection.
- Both AR root extracts and its main active compound, Shatavarin IV, showed non-toxic, dose-dependent inhibition of HIV-1 in laboratory tests, particularly effective against certain viral subtypes.
- Shatavarin IV interacted with key enzymes involved in HIV-1 replication, suggesting its potential as a therapeutic agent, while also helping to alleviate mitochondrial damage caused by the virus.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!